Camostat Mesilate Tablets 100 mg “TOWA” is an oral protease inhibitor developed for the management of pancreatic and gastrointestinal conditions associated with excessive enzyme activity. The active ingredient, camostat mesilate, is widely recognized in Japan and several international medical markets for its role in supporting pancreatic function and regulating proteolytic enzyme activity.
This medication is commonly prescribed in clinical settings for chronic pancreatitis and postoperative reflux esophagitis. Camostat mesilate works by inhibiting specific proteases involved in inflammation and tissue irritation, helping reduce symptoms and improve digestive comfort.
Manufactured by Towa Pharmaceutical Co., Ltd., this product is supplied in convenient oral tablet form and is designed for reliable absorption and therapeutic effectiveness.
Camostat mesilate belongs to a class of medications known as serine protease inhibitors. It acts by suppressing enzymes that contribute to inflammatory responses and pancreatic irritation.
Camostat Mesilate Tablets are primarily used for:
The medication may help relieve symptoms associated with chronic pancreatic inflammation, including:
Camostat mesilate may be prescribed after gastrointestinal surgery to help reduce inflammation and protect mucosal tissues affected by reflux.
In certain medical protocols, camostat mesilate may be included as supportive treatment for conditions involving abnormal enzyme activation.
Camostat mesilate inhibits trypsin and other proteolytic enzymes that can damage tissues during inflammatory processes. By controlling enzyme activity, the medication helps:
Its mechanism makes it useful in disorders where enzyme overactivity contributes to tissue damage and persistent inflammation.
Helps control excessive protease activity linked to pancreatic and digestive disorders.
Convenient tablet form for daily treatment.
Manufactured according to strict pharmaceutical standards by TOWA Pharmaceutical.
Often used as part of extended therapy plans for chronic digestive conditions.
Dosage should always be determined by a licensed healthcare professional.
Typical adult dosage may vary depending on:
Tablets are generally taken orally with water after meals.
Do not exceed prescribed dosage without medical supervision.
Some patients may experience mild or moderate side effects, including:
Rare allergic reactions may occur. Seek immediate medical attention if severe symptoms develop.
Precautions and Warnings
Before using Camostat Mesilate Tablets, inform your healthcare provider if you:
This medication should only be used under professional medical supervision.
Camostat Mesilate is mainly used for chronic pancreatitis and certain gastrointestinal inflammatory conditions.
The tablets are usually taken orally with water, typically after meals, according to physician instructions.
No. It is a protease inhibitor and not an antibiotic medication.
It may help improve symptoms related to pancreatic inflammation and digestive enzyme imbalance.
Some people may experience digestive discomfort, rash, or nausea. Serious reactions are uncommon but require medical attention.
Availability depends on local pharmaceutical regulations. Medical consultation is recommended.
Ask a question or inquire about delivery to your country
